XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Operating activities:    
Net earnings $ 37,880,000 $ 54,082,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation of fixed assets 21,890,000 21,360,000
Amortization of intangibles and deferred costs 1,747,000 1,779,000
Share-based compensation 1,931,000 1,914,000
Deferred income taxes 615,000 (15,360,000)
Gain on redemption and sales of marketable securities 284,000 (3,000)
Other 268,000 (150,000)
Changes in assets and liabilities net of effects from purchase of companies    
Decrease (increase) in accounts receivable 2,003,000 (1,821,000)
Increase in inventories (10,186,000) (12,789,000)
Decrease (increase) in prepaid expenses 172,000 (2,560,000)
Decrease in accounts payable and accrued liabilities (6,345,000) (4,555,000)
Net cash provided by operating activities 50,259,000 41,897,000
Investing activities:    
Purchases of property, plant and equipment (26,351,000) (26,281,000)
Purchases of marketable securities (19,531,000) (47,172,000)
Proceeds from redemption and sales of marketable securities 23,137,000 29,453,000
Proceeds from disposal of property and equipment 878,000 1,492,000
Other (207,000) 86,000
Net cash used in investing activities (22,074,000) (42,422,000)
Financing activities:    
Proceeds from issuance of stock 5,926,000 2,960,000
Payments on capitalized lease obligations (167,000) (188,000)
Payment of cash dividend (17,825,000) (16,239,000)
Net cash used in financing activities (12,066,000) (13,467,000)
Effect of exchange rate on cash and cash equivalents (943,000) (1,765,000)
Net increase (decrease) in cash and cash equivalents 15,176,000 (15,757,000)
Cash and cash equivalents at beginning of period 111,479,000 90,962,000
Cash and cash equivalents at end of period $ 126,655,000 $ 75,205,000